articleOphthalmologyFeb 27, 2016GREEN OA

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

JAJohn A. WellsARAdam R. GlassmanARAllison R. AyalaLMLee M. JampolNMNeil M. Bressler

Palmetto Retina Center · Jaeb Center for Health Research · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,022
total citations
FWCI
100.42
Percentile
100%
References
16
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Aflibercept
  • Ranibizumab
  • Medicine
  • Bevacizumab
  • Ophthalmology
  • Visual acuity
  • Regimen
  • Diabetic macular edema
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.